0.47 CNY
38.77 M CNY
188.61 M CNY
About SHANGHAI SERUM BIO-TECHNOLOGY
Sector
Industry
CEO
Tie Jiong Fan
Website
Headquarters
Shanghai
Founded
1999
ISIN
CNE1000059X8
FIGI
BBG00P48KW54
Shanghai Serum Bio-Technology Co., Ltd. engages in the research, development, production, and sell preventive and therapeutic drugs for biotoxins and biosafety. Its key products include equine anti-tetanus immune globulin, venin series, and rabies serum. The company was founded by Ai Xian Zhao on November 9, 1999 and is headquartered in Shanghai, China.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of 688163 is 19.03 CNY — it has increased by 2.81% in the past 24 hours. Watch SHANGHAI SERUM BIO-TECHNOLOGY stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on SSE exchange SHANGHAI SERUM BIO-TECHNOLOGY stocks are traded under the ticker 688163.
688163 stock has fallen by −11.16% compared to the previous week, the month change is a −0.99% fall, over the last year SHANGHAI SERUM BIO-TECHNOLOGY has showed a −3.60% decrease.
688163 reached its all-time high on Mar 11, 2022 with the price of 62.99 CNY, and its all-time low was 10.98 CNY and was reached on Feb 6, 2024. View more price dynamics on 688163 chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
688163 stock is 5.01% volatile and has beta coefficient of 1.11. Track SHANGHAI SERUM BIO-TECHNOLOGY stock price on the chart and check out the list of the most volatile stocks — is SHANGHAI SERUM BIO-TECHNOLOGY there?
Yes, you can track SHANGHAI SERUM BIO-TECHNOLOGY financials in yearly and quarterly reports right on TradingView.
688163 net income for the last quarter is 30.64 M CNY, while the quarter before that showed 30.83 M CNY of net income which accounts for −0.63% change. Track more SHANGHAI SERUM BIO-TECHNOLOGY financial stats to get the full picture.
SHANGHAI SERUM BIO-TECHNOLOGY dividend yield was 1.00% in 2023, and payout ratio reached 55.82%. The year before the numbers were 3.56% and 126.43% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
As of Dec 22, 2024, the company has 321.00 employees. See our rating of the largest employees — is SHANGHAI SERUM BIO-TECHNOLOGY on this list?
Like other stocks, 688163 shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI SERUM BIO-TECHNOLOGY stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So SHANGHAI SERUM BIO-TECHNOLOGY technincal analysis shows the neutral today, and its 1 week rating is buy. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating SHANGHAI SERUM BIO-TECHNOLOGY stock shows the buy signal. See more of SHANGHAI SERUM BIO-TECHNOLOGY technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.